Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
2.270
+0.040 (1.79%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Codexis Revenue
In the year 2024, Codexis had annual revenue of $59.35M, down -15.39%. Codexis had revenue of $21.46M in the quarter ending December 31, 2024, a decrease of -19.20%.
Revenue (ttm)
$59.35M
Revenue Growth
-15.39%
P/S Ratio
2.82
Revenue / Employee
$315,665
Employees
188
Market Cap
188.04M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 59.35M | -10.80M | -15.39% |
Dec 31, 2023 | 70.14M | -68.45M | -49.39% |
Dec 31, 2022 | 138.59M | 33.84M | 32.30% |
Dec 31, 2021 | 104.75M | 35.70M | 51.69% |
Dec 31, 2020 | 69.06M | 598.00K | 0.87% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
CDXS News
- 14 days ago - Codexis Announces Byron Dorgan to Retire from Board of Directors - GlobeNewsWire
- 6 weeks ago - Codexis Announces New Employment Inducement Grants - GlobeNewsWire
- 7 weeks ago - Codexis, Inc. (CDXS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th - GlobeNewsWire
- 2 months ago - Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board - GlobeNewsWire
- 3 months ago - Codexis Appoints Christos Richards to Board of Directors - GlobeNewsWire
- 5 months ago - Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 5 months ago - Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics - GlobeNewsWire